Fyrn is a specialist market access and reimbursement agency supporting healthcare innovators in navigating complex global payer and access environments.
We work across med-tech, biotech and digital health innovators to align clinical value, economic evidence and policy realities — enabling structured, defensible decisions across mature healthcare systems.
Market access is rarely a regulatory problem. It is not a single submission.
It is a systems-level decision shaped by reimbursement architecture, evidence alignment, pricing strategy and stakeholder behaviour.
Too often, these elements are approached in isolation.
Fyrn was founded to provide focused, integrated advisory grounded in deep system literacy – without the dilution of large consultancy structures.
Fyrn draws on over 25 years of professional experience across UK, European, US and APAC healthcare systems.
This experience includes advisory work spanning:
The consistent focus has been the same:
Aligning clinical value, economic modelling, real-world evidence and reimbursement strategy to support sustainable funding decisions.
Fyrn operates as a founder-led advisory model — providing senior-level engagement from strategy framing through to implementation support.
Effective access strategy requires integration across:
Professional experience reflects prior senior roles and advisory engagements within life sciences and healthcare organisations across global markets.
Fyrn partners with organisation who recognise that access is not an endpoint, but as structured decision process requiring clarity, alignment and informed strategic judgement.
